Actionable news
0
All posts from Actionable news
Actionable news in NBIX: Neurocrine Biosciences, Inc.,

Neurocrine Biosciences Inc.

Average Recommendation: Buy Average Target Price: 69.50
Number of Ratings: 8 Current Quarters Estimate: -0.49
FY Report Date: 12 / 2016 Current Year's Estimate: -1.93
Last Quarter's Earnings: -0.22 Median PE on CY...

More